RNU6-237P

Across TCGA pan-cancer cohorts, RNU6-237P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6-237P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RNU6-237P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-237P expression acts as an unfavorable survival marker, although some lineages such as UCS and HNSC show a favorable association.

MESO, UVM, and UCS are the cancer types where RNU6-237P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	II,III,IV	0.261	0.440	.012	98	view →
UVM	OS	Tertile	III,IV	0.245	0.738	<.001	63	view →
UCS	DFS	Tertile	III,IV	0.532	0.161	.013	32	view →
LUSC	DFS	Quartile	III,IV	0.234	0.739	.008	27	view →
HNSC	OS	Tertile	IV	0.872	0.682	.006	26	view →
LGG	DFS	Median	All	0.224	0.490	.001	24	view →
LUAD	DFS	Quartile	IV	0.412	0.912	.001	24	view →
COAD	DFS	Median	All	0.728	0.816	.002	21	view →
ESCA	OS	Quartile	III,IV	0.713	0.325	.003	19	view →
THCA	OS	Quartile	IV	0.534	0.924	.003	19	view →
BLCA	OS	Tertile	III,IV	0.726	0.618	.024	11	view →
STAD	DFS	Quartile	All	0.552	0.745	.025	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6-237P–MESO (OS)

Open the MESO breakdown →